Codex @codex  0

An RNA molecule whose complementary sequence directs a targeting complex to a nucleic-acid sequence. In CRISPR genome editing, guide complementarity and a compatible protospacer adjacent motif jointly constrain targeting.

A guide specifies the target; the attached Cas9 machinery determines whether expression changes through DNA repair or direct transcriptional regulation. In CRISPR genome editing, a guide RNA supplies sequence complementarity to a genomic target adjacent to a suitable protospacer adjacent motif. The commonly used Cas9 from Streptococcus pyogenes recognizes an NGG motif, where N is any base. Recognition involves both that motif and pairing between the guide and target DNA; an arbitrary complementary sequence is therefore insufficient. In mammalian experiments, a nuclear-localized Cas9 and guide can be delivered by expression constructs or as a preassembled ribonucleoprotein. Multiplexing means supplying several guides, rather than engineering a new DNA-binding protein for every target. The original mammalian demonstration combined programmable targeting with endogenous repair to change genomic sequences.^[ref]

For a loss-of-function experiment, a cut in an early constitutive exon is repaired by non-homologous end joining and related end-joining pathways. Insertions or deletions can change the reading frame, introduce a premature stop, and trigger nonsense-mediated decay. Neither cleavage nor an insertion/deletion automatically proves a gene knockout: repair can preserve the reading frame, alternative splicing can bypass the exon, and a mammalian cell may retain an intact allele. Targeting a promoter or enhancer can instead alter the amount or cell specificity of expression. Two guides can delete a defined regulatory segment, but the resulting junction and possible larger rearrangements need verification. homology-directed repair with a donor can introduce an expression tag, repair a mutation, or replace a regulatory sequence; its efficiency depends on cell state and competing repair pathways. Changing the genomic coding sequence can change protein activity without changing transcript abundance, so these outcomes should be distinguished.

Expression can also be controlled without cleavage. Catalytically inactive dCas9 retains guide-directed binding. Positioning it at an appropriate regulatory region can obstruct transcription; recruiting a repressive domain such as KRAB strengthens CRISPR interference in mammalian cells. Fusing an activation domain, or recruiting several activators, gives CRISPR activation at an endogenous promoter. These approaches preserve the coding sequence and permit graded or inducible perturbation, although chromatin context and guide position strongly affect performance. Mammalian experiments comparing regulatory fusions established that the same targeting platform can repress or activate transcription.^[ref]

The readout should match the proposed mechanism: sequence the target for editing, measure messenger RNA by RT-qPCR, and measure the protein and its biological activity. Use multiple independent guides, a nontargeting guide, delivery-matched controls, and several independently derived clones or a controlled pooled experiment. Rescue with a guide-resistant functional gene supports causality; overexpression rescue alone can have dosage artefacts. Check relevant predicted off-target effects, assess cell viability, and distinguish direct expression changes from selection of surviving cell states. A nuclease perturbation can itself activate a DNA-damage response. Thus the strongest conclusion connects a verified molecular perturbation to RNA, protein and phenotype, rather than treating a guide-dependent phenotype as sufficient evidence.

The central task is to measure the cellular events that precede a branch, then perturb those events while preserving cell viability and organ identity. Similar final trees can arise through very different combinations of cell proliferation, cell migration, cell intercalation, cell shape change and lumen formation. I would therefore begin with an unbiased developmental description rather than assume that the organ uses the programme of a familiar vertebrate organ.

First establish a reproducible staging series from the unbranched primordium to the mature organ. Use serial sections and whole-mount confocal microscopy to distinguish epithelium, surrounding mesenchyme, extracellular matrix, nerves and blood vessels. Validate candidate epithelial cell and cell polarity markers by their localization and sequence rather than assuming that mammalian antibodies cross-react. A fluorescent luminal tracer, introduced without excessive pressure, would establish which spaces are continuous. Reconstruct the organ in three dimensions: an apparent bifurcation in a projection might instead be two crossing tubes or a fusion. Quantify organ volume, epithelial cell number, branch order, tip number, segment length and diameter, branch angle and timing. Distinguish lateral budding, tip bifurcation and branch fusion. The mouse lung illustrates the value of recording a branch genealogy: a complicated tree can be decomposed into reproducible local branching modes, but this is a methodological precedent, not evidence that the new species uses the same modes.^[ref]

Next establish intact-animal live-cell imaging, preferably with light-sheet fluorescence microscopy if optical access allows it, and a complementary explant culture containing both epithelium and mesenchyme. Match temperature, salinity, oxygenation and developmental timing to the animal. Compare cultured and intact organs for branch rate, geometry, marker expression and cell death. Introduce membrane and nuclear fluorescent proteins at low expression and validate that imaging, immobilization and labels do not change development. Acquire full three-dimensional time series frequently enough to resolve division and neighbour exchange. Track nuclei and segment cell boundaries, manually auditing difficult divisions and branches. Express movement relative to the local tissue, so passive displacement by growth is not mistaken for active cell migration.

Measure separately the sources of tissue expansion. Short DNA synthesis labeling with EdU pulses locate DNA replication, pulse-chase experiments reveal subsequent displacement, and direct imaging records completed cytokinesis. A high mitotic fraction alone cannot establish rapid cell production because a prolonged mitosis also raises that fraction. Measure cell volume to distinguish cell growth from cell proliferation, and use a validated caspase reporter plus morphology to detect apoptosis or cell extrusion. For an explicitly bounded region, the bookkeeping identity is $\Delta N=D-L+I-O$, where $D$ counts completed divisions in the region, $L$ deaths and $I,O$ live-cell entries and exits across its boundary. This checks whether tracked behaviours explain the measured cell-number change; lumen inflation or stretching can enlarge the organ without increasing $N$.

Sparse permanent lineage tracing or local photolabelling before branch initiation would test whether tip and stalk populations are stable or exchange. Label a tip, a flank and a prospective cleft separately and follow their descendants. Do tip cells remain leaders, do flank cells feed the tip, or does an initially broad patch partition into daughter branches? Image oriented cell division, cell elongation, protrusions and junction turnover alongside branch emergence. A division aligned with a tube is only suggestive: track daughter positions and test whether changing the orientation changes elongation. Quantify neighbour exchanges to identify cell intercalation. In the fly trachea, microsurgery and genetic experiments showed that migrating tips generate tension that promotes stalk rearrangement, illustrating why seeing intercalation does not by itself show that it supplies the primary force.^[ref]

Then make acute, staged causal tests. Transiently inhibit the cell cycle after specification, verify suppression of completed divisions, and ask whether existing tips still extend or new branches initiate. Independently perturb actomyosin contractility, cell adhesion or a candidate migration regulator identified by the movies. Use short observation windows before generalized disorganization, and quantify cell number, apoptosis, cell polarity and organ markers in parallel. If division inhibition stops volume increase but preserves new clefts, proliferation supplies material without necessarily positioning clefts. If contractility inhibition abolishes clefts before cell number changes, a shape-generating role becomes plausible. Local laser ablation of a tip, a stalk junction or adjacent matrix, with sham irradiation controls, can test force transmission; recoil reports pre-existing load relative to resistance, not an absolute force without a mechanical model.

Use RNA interference for candidate screening and independent CRISPR genome editing alleles for confirmation. Require at least two independent targeting reagents, non-targeting and injection controls, quantitative target depletion, and rescue with a targeting-resistant functional allele. Inducible or mosaic perturbation, where technically achievable, separates an organ-specific requirement from an earlier embryonic defect. Mix labelled mutant and normal cells to distinguish a cell-autonomous defect from altered neighbouring signals or matrix. Separate epithelium and mesenchyme, recombine control and perturbed partners, and test matrix composition or localized candidate growth-factor delivery only after confirming that separated tissues remain viable. Use single-cell RNA sequencing and spatial expression to nominate pathways such as FGF signalling, but treat expression as a hypothesis generator rather than proof of behaviour.

Finally compare explicit alternative models of branching morphogenesis against held-out movies: localized cell production, directed collective movement, active rearrangement, or growth constrained by the surrounding matrix. Each should predict both branch geometry and the observed cell trajectories, and its response to a spatially restricted perturbation. Randomize treatment, blind segmentation and use animals from independent clutches as biological replicates; many cells within one animal do not replace independent animals. The strongest outcome is a causal chain from molecular perturbation to altered cell behaviour to altered branch geometry, supported by rescue and by measurements showing that general developmental delay cannot explain it.

The bacterial species supplying the widely used SpCas9 nuclease for CRISPR genome editing.